Tacalcitol
Alternative Names: Bonalfa; Curatoderm; Psoraderm; Psoravit; TV 02; TV-02HLatest Information Update: 25 Sep 2021
At a glance
- Originator Teijin Pharma
- Developer Profex; Teijin Pharma
- Class Anti-inflammatories; Antiallergics; Antipruritics; Antipsoriatics; Dihydroxycholecalciferols; Small molecules
- Mechanism of Action Vitamin D3 stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Plaque psoriasis; Psoriasis
Most Recent Events
- 17 Apr 2015 No recent reports on development identified - Preregistration for Plaque psoriasis in China (Topical)
- 20 Sep 2010 Preregistration for Plaque psoriasis (20 µg/g dose) in China (Topical ointment)
- 27 Jun 2006 Launched for Plaque psoriasis (20 µg/g dose) in Japan (Topical lotion)